Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL
Annals of Clinical and Translational Neurology · 06.05.2026
DOI: 10.1002/acn3.70424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 06.05.2026. Verfasst von Léa Aguilhon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministère de la Santé, Agence Nationale de la Recherche, European Joint Program for Rare Disease - Horizon H2020 - CADANHIS.
Themen: Schlaganfall
Abstract (Originalsprache)
Objective
Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact on long‐term progression remains unclear. This study assesses mutation location effects on post‐first stroke clinical trajectories.
Methods
Clinical data from a large cohort were analyzed (Patients EGFR 1–6 mutation group n = 210 and 7–34 mutation group n = 116) with target emulated trial framework. To study the impact of mutation location on stroke recurrence, disability (modified Rankin score ≥ 3) and mortality, following a first stroke event. Propensity score matching was used to balance covariates between mutation location groups and principal stratification to consider truncation by death. Events occurrence differences were compared using Restricted Mean Survival Time at 2, 5, 10 and 15 years.
Results
At first stroke, patients with mutation in domains 1–6 were younger than those in the 7–34 mutation group (49.51 ± 7.4 vs. 55.00 ± 7.4 years). Ten years after first stroke event, mortality occurred slightly later in the 7–34 group (9.63 [9.33–9.92] vs. 9.11 [8.71–9.52] years, p = 0.04), also at 15 years (14.0 [13.42–14.63] vs. 12.4 [11.62–13.24] years; p = 0.002). Second stroke occurrence did not differ between groups. Time beyond modified Rankin of 3 slightly differed between groups at 5 and 10 years, with a difference of 0.22 [0.01–0.044] and 0.72 [0.14–1.30] year respectively ( p = 0.044 and 0.017).
Interpretation
Although NOTCH3 variants location influences the delay to the first stroke, it has no or little impact on the recurrence of stroke, risk of disability and death after the first stroke manifestation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France.
- GENOVASC, INSERM U1127, Paris Brain Institute (Institut du Cerveau-ICM), Paris, France.
- Centre de Référence National des Maladies Rares des Vaisseaux du Cerveau et de L'œil (CERVCO) and Centre Neurovascular Translationnel (CNVT), FHU-NeuroVasc-2030, Hopital Lariboisiére APHP, Paris, France.
- Université Paris-Cité, Paris, France.
ORCID-Profile: Léa Aguilhon, Hugues Chabriat
Förderung
- Ministère de la Santé
- Agence Nationale de la Recherche
- European Joint Program for Rare Disease - Horizon H2020 - CADANHIS
Zitieren
APA
Aguilhon, L., Chabriat, H., Hervé, D., Guey, S., Du Montcel, S. T., & Ortholand, J. (2026). Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70424
Vancouver
Aguilhon L, Chabriat H, Hervé D, Guey S, Du Montcel ST, Ortholand J. Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70424
BibTeX
@article{Aguilhon2026,
author = {Aguilhon, Léa and Chabriat, Hugues and Hervé, Dominique and Guey, Stéphanie and Du Montcel, Sophie Tezenas and Ortholand, Juliette},
title = {Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70424}
}
EUVIMED